NCT01127217View on ClinicalTrials.gov

Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Stage 2 Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

149

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Hypertension
Interventions
DRUG

amlodipine/losartan

amlodipine 5mg/losartan 50mg, amlodipine 10mg/losartan 50mg (+HCTZ 12.5mg)

DRUG

amlodipine

amlodipine 5mg, amlodipine 10mg (+ HCTZ 12.5mg)

Trial Locations (1)

Unknown

8 Sites, Seoul

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT01127217 - Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Stage 2 Hypertension | Biotech Hunter | Biotech Hunter